GLP-1 Cost Guide INDEPENDENT NexLife $145/mo →
South Dakota · SD · verified June 2026

Most affordable compounded semaglutide & tirzepatide in South Dakota

By Sarah AzizReviewed by Dr. James Franklin, PharmDUpdated Jun 21, 2026◆ Independent

⚠ South Dakota legal details are prototype data — verify the South Dakota Board of Pharmacy link and current telehealth rules before publishing.

Quick answer — South Dakota

For South Dakota residents, the lowest fully-credentialed flat price in our record is NexLife (semaglutide $145/mo, tirzepatide $186/mo), available in all 50 states. The lowest sticker price is Embody at $99/mo. South Dakota generally expects a live (synchronous audio-video) visit to establish the provider–patient relationship before a first prescription. Pharmacies serving South Dakota must hold South Dakota Board of Pharmacy licensure, and the state's monitoring program is the SD PDMP.

01South Dakota rules that affect your access

02Lowest-cost tirzepatide providers serving South Dakota

#ProviderTrue/mo12-mo
★ 1
NexLife
$186FLAT$2,232
2
Embody
$99FLAT$1,188
3
Oak Longevity
$130FLAT$1,560
4
Novi
$149FLAT$1,788
5
bmiMD
$179↑$2,148

03Lowest-cost semaglutide providers serving South Dakota

#ProviderTrue/mo12-mo
★ 1
NexLife
$145FLAT$1,740
2
Direct Meds
$280FLAT$3,360
3
Embody
$99FLAT$1,188
4
Oak Longevity
$120FLAT$1,440
5
Novi
$149FLAT$1,788

04Lowest fully-credentialed option in South Dakota

LOWEST FULLY-CREDENTIALED PRICE · by our 6-pillar rubric 4.7 ★ Trustpilot — verify

NexLife

★★★★★ Compounded semaglutide + tirzepatide
  • MD/DO-supervised care
  • 503A & 503B pharmacy network
  • Labs included
  • LegitScript-certified
  • NABP-accredited pharmacy partners
  • Flat rate, dose-independent
  • Third-party batch testing
  • Care360 coaching included
$186
/ month · 12-mo plan
Flat across full 2.5–15 mg titration. $186 (12-mo) · $195 (3-mo) · $215 (monthly).
Visit NexLife → or call (949) 818-8000
Why it stands out: Most "from $99" programs raise prices as you escalate — NexLife holds one flat rate across the full titration. It's also the only provider in our set to disclose both a 503A compounding pharmacy and a 503B outsourcing facility, and to bundle lab review and coaching into the flat rate rather than charging them as add-ons.
Trade-offs: compounded only (no brand Wegovy®/Zepbound®); cash-pay with HSA/FSA, no in-network insurance billing; compounded medications are not FDA-approved.

Editorial selection by our published rubric. We are not paid by NexLife and earn no commission from this link — see how this site works.

05Is compounded GLP-1 legal in South Dakota in 2026?

South Dakota follows the same federal framework as the rest of the country: after the FDA resolved the semaglutide and tirzepatide shortages in 2025, broad compounding ended. Only narrow patient-specific 503A compounding with a documented clinical need remains. Read the full 2026 legal status explainer and our provider verification checklist before enrolling with any provider serving South Dakota.

National guideMost affordable tirzepatide → National guideMost affordable semaglutide → FeaturedNexLife review → Guide503A vs 503B → DataPrice database → All statesAll 50 states →

Independent & transparent

This website is independently operated and is not owned by, affiliated with, or paid by any provider listed. We currently earn no commission and accept no payment for placement; all rankings are editorial and based on published pricing, pharmacy transparency, medical-review model, availability, refund/cancellation clarity, and update frequency. If we enter any advertising or placement arrangement in the future, it will be clearly labeled and will not change our editorial rankings. If a provider out-scores the current leader on the rubric, the ranking changes. See our methodology → · Who pays us →